Xiaopeng Mao

No. 58, Zhongshan No. 2 Road
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Targeting VSIG4+ tissue-resident macrophages enhances T cell cytotoxicity and immunotherapy efficacy in cancer.

Targeting VSIG4+ tissue-resident macrophages enhances T cell cytotoxicity and immunotherapy efficacy in cancer.

Journal: Developmental cell
Published: October 23, 2024

Integration of PSAd and multiparametric MRI to forecast biopsy outcomes in biopsy-naïve patients with PSA 4~20 ng/ml.

Integration of PSAd and multiparametric MRI to forecast biopsy outcomes in biopsy-naïve patients with PSA 4~20 ng/ml.

Journal: Frontiers in oncology
Published: April 08, 2024

MTHFD2 Enhances cMYC O-GlcNAcylation to Promote Sunitinib Resistance in Renal Cell Carcinoma.

MTHFD2 Enhances cMYC O-GlcNAcylation to Promote Sunitinib Resistance in Renal Cell Carcinoma.

Journal: Cancer research
Published: January 05, 2024

Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.

Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.

Journal: BMC genomics
Published: December 19, 2023

Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis.

Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis.

Journal: Frontiers in oncology
Published: June 19, 2023

An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.

An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.

Journal: Cancer cell international
Published: January 25, 2023

Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis.

Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis.

Journal: Asian journal of surgery
Published: November 22, 2022

Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis.

Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis.

Journal: Frontiers in oncology
Published: November 18, 2022

A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer.

A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer.

Journal: Frontiers in genetics
Published: November 12, 2022

Correction: Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2.

Correction: Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2.

Journal: Journal of experimental & clinical cancer research : CR
Published: June 18, 2022

Sex Hormones Had Mediation in the Connection Between Certain Blood Routine Parameters and Bone Loss.

Sex Hormones Had Mediation in the Connection Between Certain Blood Routine Parameters and Bone Loss.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry
Published: May 07, 2022

The impact of tumor size on the survival of patients with small renal masses: A population-based study.

The impact of tumor size on the survival of patients with small renal masses: A population-based study.

Journal: Cancer medicine
Published: November 19, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026